N,N-dimethylbiguanide-4-chlorophenoxyacetic acid

Known as: N,N-dimethylbiguanide-p-chlorophenoxyacetic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1961-2016
01219612016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The new complexes M(DMBG)(2)(ClO(4))(2) (M:Mn, Ni, Cu and Zn; DMBG: N,N-dimethylbiguanide) have been synthesized and… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
1999
1999
Nearly 30% of patients treated with metformin experience gastrointestinal side effects. Since release of 5-hydroxytryptamine (5… (More)
Is this relevant?
1997
1997
The synthesis of (metformin) tetrachloroplatinum (IV) was investigated (metformin is N,N-dimethylbiguanide). It crystallizes with… (More)
Is this relevant?
1987
1987
Metabolic and clinical peculiarities of patients with peripheral vascular disease (PVD) were evaluated in two studies. In the… (More)
Is this relevant?
1984
1984
We evaluated the effect of metformin (N,N-dimethylbiguanide), a biguanide known to be less toxic than phenformin, on insulin… (More)
Is this relevant?
1983
1983
The effect of metformin (N,N-dimethylbiguanide) on the rate-limiting enzymes of cholesterol metabolism was observed. 3-Hydroxy-3… (More)
Is this relevant?
Highly Cited
1978
Highly Cited
1978
Kinetic parameters of metformin (N,N-dimethylbiguanide), an anti-diabetic reported to be associated with a lower number of… (More)
Is this relevant?
1977
1977
The triglyceride-lowering effect of metformin (N,N-dimethylbiguanide) was tested in a series of patients with stable… (More)
Is this relevant?